Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Association between Psoriasis Area and Severity Index Score and atherosclerotic risk in psoriasis patients using the
Airi Kobayashi1, Hitoshi Terui1, Ryoko Shimada-Omori1
1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Insights
Psoriasis severity, measured by the Psoriasis Area and Severity Index (PASI), is linked to higher cardiovascular disease risk in Japanese adults. The Hisayama Score can help assess this risk, especially in men with high PASI scores.
Area of Science:
- Dermatology
- Cardiology
- Public Health
Background:
- Psoriasis is a chronic inflammatory skin condition associated with increased cardiovascular disease (CVD) risk.
- The Hisayama Score is a validated tool for assessing cardiovascular and stroke risk in Japan.
Purpose of the Study:
- To investigate the association between psoriasis severity (PASI) and cardiovascular risk using the Hisayama Score in a Japanese population.
- To evaluate the utility of the Hisayama Score in stratifying cardiovascular risk among psoriasis patients.
Main Methods:
- Retrospective analysis of 71 psoriasis patients (aged 40-79) without pre-existing comorbidities.
- Stratification into low, moderate, and high cardiovascular risk groups based on blood pressure, lipids, and smoking history.
- Application of the Hisayama Score to assess cardiovascular risk in relation to PASI scores.
Main Results:
- Higher PASI scores were significantly associated with increased cardiovascular risk (p=0.003).
- Male patients with PASI scores >10 were more often in moderate or high-risk groups (p=0.049).
- Systolic blood pressure emerged as an independent predictor of cardiovascular risk.
Conclusions:
- Psoriasis severity correlates with elevated cardiovascular risk, underscoring the need for proactive cardiovascular risk management in these patients.
- The Hisayama Score is a useful tool for assessing cardiovascular risk in Japanese psoriasis patients.
- Dermatologists should consider interdisciplinary approaches for managing cardiovascular risk in psoriasis patients.
Abstract:
Psoriasis is a chronic immune-mediated skin disorder causing systemic inflammation, which significantly increases the risk of cardiovascular disease (CVD). In Japan, the Hisayama Score was recently introduced as a comprehensive tool to assess coronary artery disease and stroke risk. This retrospective study represents the first investigation applying the Hisayama Score to psoriasis patients to determine the association between the Psoriasis Area and Severity Index (PASI) and cardiovascular risk. We analyzed data from 119 patients aged 40-79 visiting Tohoku University Hospital between 2010 and 2022. After excluding 48 patients with pre-existing comorbidities like diabetes and chronic kidney disease, 71 participants remained. Patients were stratified into low, moderate, and high-risk groups based on blood pressure, lipid profiles, and smoking history. Results showed that higher PASI scores were significantly associated with increased cardiovascular risk (p = 0.003). Notably, male patients with PASI scores exceeding 10 were frequently categorized into moderate or high-risk groups (p = 0.049). Additionally, systolic blood pressure was identified as an independent predictor. These findings suggest that psoriasis severity correlates with elevated cardiovascular risk, validating the Hisayama Score's utility in this population and highlighting the critical need for dermatologists to implement proactive, interdisciplinary risk management strategies.
More Related Videos
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
05:51A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction